Altered neurofilament expression does not contribute to Lewy body formation

American Journal of Pathology

Volumn 148, Issue 1, 1996, Pages 267-272

  Bergeron, Catherine ^a,b   Petrunka, Connie ^a   Weyer, Luitgard ^a   Pollanen, Michael S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROFILAMENT PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN TISSUE; LEWY BODY; NEUROFILAMENT; PRIORITY JOURNAL; RED NUCLEUS; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; HUMANS; LEWY BODIES; MIDDLE AGED; NEUROFILAMENT PROTEINS; NEURONS; PARKINSON DISEASE; RNA, MESSENGER;

EID: 0030030881     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kato T, Katigiri T, Hirano A, Sasaki H, Arai S: Sporadic lower motor neuron disease with Lewy body-like inclusions, a new subgroup? Acta Neuropathol 1988, 76 208-211
2. Bergeron C, Pollanen M: Lewy bodies in Alzheimer disease one or two diseases? Alzheimer Dis Assoc Disord 1989, 3:197-204
3. Goldman J, Yen S-H, Chiu F-C, Peress N: Lewy bodies of Parkinson's disease contain neurofilament antigens Science 1983, 221. 1082-1084
4. Forno L, Sternberger L, Sternberger N, Strefling A, Swanson K, Eng L: Reactions of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett 1986, 64253-258
5. Galloway P, Grundke-Iqbal I, Iqbal K, Perry G: Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 1988, 47.654-663
6. Schmidt ML, Murray J, Lee VM-Y, Hill WD, Wertkin A, Trojanowski JQ: Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies Am J Pathol 1991, 139 53-65
7. Pollanen MS, Bergeron C, Weyer L: Detergent-insoluble cortical Lewy body fibrils share epitopes with neurofilament and τ. J Neurochem 1992, 58:1953-1956
8. Pollanen MS, Bergeron C, Weyer L. Deposition of detergent-resistant neurofilaments into Lewy body fibrils. Brain Res 1993, 603:121-124
9. Hill WD, Lee VM-Y, Hurtig HI, Murray JM, Trojanowski JQ: Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies. J Comp Neurol 1991, 309.150-160
10. Love S, Saitoh T, Quijada S, Cole G, Terry R: ALz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies J Neuropathol Exp Neurol 1988, 47:393-405
11. Bancher C, Lassmann H, Budka H, Jellinger K, Grudke-Iqbal I, Iqbal K, Wiche G, Seitelberger F, Wisniewski HM An antigenic profile of Lewy bodies. immunocytochemical indication for protein phosphorylation and ubiquitination J Neuropathol Exp Neurol 1989, 48.81-93
12. Lowe J, Blanchard A, Morrell K: Carboxy-terminal hydrolase (PGP 9 5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative disease J Pathol 1990, 161:153-160
13. Galloway PG, Mulvihill P, Perry G: Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 1992, 140:809-822
14. Lewis S, Cowan NJ Genetics, evolution, and expression of the 68,000-mol-wt neurofilament protein: isolation of a cloned cDNA probe. J Cell Biol 1985, 100: 843-850
15. Julien J-P, Grosveld F, Yazdanbaksh K, Flavell D, Meijer D, Mushynski W. The structure of a human neurofilament gene (NF-L). a unique exon-intron organization in the intermediate filament gene family. Biochim Biophys Acta 1987, 909.10-20
16. Somerville MJ, Bergeron C, Yoong LK, McLachlan DR. Percy ME: Neuronal expression of the light chain neurofilament and superoxide dismutase-1 genes in temporal lobe of Alzheimer brain Alzheimer's Disease Basic Mechanisms, Diagnosis and Therapeutic Strategies. Edited by K Iqbal, D McLachlan, B Windblad, H Wisniewski. New York, John Wiley and Sons, 1991, pp 237-241
17. Somerville MJ, Percy ME, Bergeron C, Yoong LKK, Grima EA, McLachlan DRC. Localization and quantitation of 68 kDA neurofilament and superoxide dismutase-1 mRNA in Alzheimer brain. Mol Brain Res 1991, 9:1-8
18. Bergeron C, Beric-Maskarel K, Muntasser S, Weyer L, Somerville MJ, Percy ME: Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J Neuropathol Exp Neurol 1994, 53.221-230
19. Pardue ML. In situ hybridization. Nucleic Acid Hybridization. A Practical Approach Edited by BD Hames, SJ Higgins Oxford, IRL Press, 1985, pp 179-202
20. Harrison PJ, Pearson RCA: In situ hybridization histochemistry and the study of gene expression in the human brain. Prog Neurobiol 1990, 34:271-312
21. Barton A, Pearson R, Najlerahim A, Harrison P: Pre-and postmortem influences on brain RNA. J Neurochem 1993, 61:1-11
22. Hoffman PN, Cleveland DW: Neurofilament and tubulin expression recapitulates the developmental program during axonal regeneration: induction of a specific β-tubulin isotype Proc Natl Acad Sci USA 1988, 85: 4530-4533
23. Tetzlaff W, Alexander SH, Miller FD, Bisby MA Response of facial and rubrospinal neurons to axotomy changes in mRNA expression for cytoskeletal proteins and GAP-43 J Neurosci 1991, 11:2528-2544
24. Muma NA Troncoso JC, Hoffman PN, Koo EH. Price DL Aluminum neurotoxicity altered expression of cytoskeletal genes Mol Brain Res 1988, 3:115-122
25. Parhad IM, Krekoski CA, Mathew A, Tran PM: Neuronal gene expression in aluminum myelopathy Cell Mol Neurobiol 1989, 9.123-138
26. Strong MJ, Mao K, Nerukar VR, Wakayama I, Yanagihara R, Garruto RM. Dose-dependent selective supression of light (NFL) and medium (NFM) but not heavy (NFH) molecular weight neurofilament mRNA levels in acute aluminum neurotoxicity. Mol Cell Neurosci 1994, 5 319-326
27. Guillemette JG, Wong L, McLachlan DRC, Lewis PN. Characterization of messenger RNA from the cerebral cortex of control and Alzheimer afflicted brain J Neurochem 1987, 47:987-997
28. Clark AW, Krekoski CA, Parhad IM, Liston D, Julien J-P, Hoar DI. Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex Ann Neurol 1989, 25:331-339
29. Yamasaki H, Bennett GS, Itakura C, Mizutani M: Defective expression of neurofilament protein subunits in hereditary hypototrophic axonopathy of quail. Lab Invest 1992, 66 734-743
30. Eyer J, Peterson A: Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein. Neuron 1994, 12.389-405
31. Hoffman PH, Pollock SC, Striph GG: Altered gene expression after optic nerve transection: reduced neurofilament expression as a general response to axonal injury. Exp Neurol 1993, 119 32-36
32. Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y: Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 1990, 38.245-253
33. Hill WD, Arai M, Cohen JA, Trojanowski JQ Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta. J Comp Neurol 1993, 329:328-336
34. Pollanen MS, Dickson DW, Bergeron C: Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993, 52:183-191